WO2001075008A3 - Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide - Google Patents
Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide Download PDFInfo
- Publication number
- WO2001075008A3 WO2001075008A3 PCT/CN2001/000270 CN0100270W WO0175008A3 WO 2001075008 A3 WO2001075008 A3 WO 2001075008A3 CN 0100270 W CN0100270 W CN 0100270W WO 0175008 A3 WO0175008 A3 WO 0175008A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- helix
- loop
- polynucleotide encoding
- same
- polypeptide
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 101710093772 Helix-loop-helix protein 11 Proteins 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 208000019838 Blood disease Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000021642 Muscular disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000013020 embryo development Effects 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 208000014951 hematologic disease Diseases 0.000 abstract 1
- 208000018706 hematopoietic system disease Diseases 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention concerne un nouveau polypeptide, une protéine hélicase-anneau-hélicase 11, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniq2ues recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment de troubles musculaires, de maladies immunitaires, de toutes sortes de tumeurs, de troubles du développement des embryons, de troubles du développement de la croissance, d'inflammations, de l'hémopathie et de l'infection par VIH. L'invention concerne aussi l'antagonsite agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine hélicase-anneau-hélicase 11.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU46309/01A AU4630901A (en) | 2000-03-02 | 2001-02-26 | A novel polypeptide, helicase-ring-helicase protein 11 and the polynucleotide encoding the polypeptide |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN00111828.5 | 2000-03-02 | ||
| CN 00111828 CN1311222A (zh) | 2000-03-02 | 2000-03-02 | 一种新的多肽——人螺旋－环－螺旋蛋白11和编码这种多肽的多核苷酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2001075008A2 WO2001075008A2 (fr) | 2001-10-11 |
| WO2001075008A3 true WO2001075008A3 (fr) | 2002-02-07 |
Family
ID=4581724
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/CN2001/000270 WO2001075008A2 (fr) | 2000-03-02 | 2001-02-26 | Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN1311222A (fr) |
| AU (1) | AU4630901A (fr) |
| WO (1) | WO2001075008A2 (fr) |
-
2000
- 2000-03-02 CN CN 00111828 patent/CN1311222A/zh active Pending
-
2001
- 2001-02-26 AU AU46309/01A patent/AU4630901A/en not_active Abandoned
- 2001-02-26 WO PCT/CN2001/000270 patent/WO2001075008A2/fr active Application Filing
Non-Patent Citations (4)
| Title |
|---|
| BIOCHEM. BIOPHYS. RES. COMMUN., vol. 231, no. 3, 1997, pages 628 - 634 * |
| CURR. OPIN. GENET. DEV., vol. 2, no. 2, 1992, pages 243 - 248 * |
| CURR. OPIN. NEUROBIOL., vol. 7, no. 1, 1997, pages 13 - 20 * |
| MOL. CELL. BIOL., vol. 12, no. 3, 1992, pages 1031 - 1042 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001075008A2 (fr) | 2001-10-11 |
| AU4630901A (en) | 2001-10-15 |
| CN1311222A (zh) | 2001-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001075008A3 (fr) | Nouveau polypeptide, protéine hélicase-anneau-hélicase 11, et polynucleotide codant pour ce polypeptide | |
| WO2001085903A3 (fr) | Nouveau polypeptide, proteine humaine 9 contenant un fragment de sequence particulier de p5cr, et polynucleotide codant pour ce polypeptide | |
| WO2001078755A3 (fr) | Nouveau polypeptide, proteine humaine de mutation 9 de l'ataxie-telangiectasie, et polynucleotide codant pour ce polypeptide | |
| WO2001075059A3 (fr) | Nouveau polypeptide, proteine humaine 11 de regulation de gtp, et polynucleotide codant pour ce polypeptide | |
| WO2001074995A3 (fr) | Nouveau polypeptide, protéine humaine de mutation 15 de l'ataxie telangiectasie, et de polynucléotide codant pour ce polypeptide | |
| WO2001075021A3 (fr) | Nouveau polypeptide, proteine humaine associee au transport de glucose 10, et polynucleotide codant pour ce polypeptide | |
| WO2001083685A3 (fr) | Nouveau polypeptide, proteine cap 10, et polynucleotide codant pour ce polypeptide | |
| WO2001083682A3 (fr) | Nouveau polypeptide, proteine pax humaine 11.6, et polynucleotide codant pour ce polypeptide | |
| WO2002008422A1 (fr) | Nouveau polypeptide, proteine du myotube humaine 10.56, et polynucleotide codant ce polypeptide | |
| WO2001075020A3 (fr) | Nouveau polypeptide, neuroproteine humaine y 11, et polynucleotide codant pour ce polypeptide | |
| WO2001083687A3 (fr) | Nouveau polypeptide, proteine pax humaine 23, et polynucleotide codant pour ce polypeptide | |
| WO2002000821A3 (fr) | Nouveau polypeptide, proteine humaine plp 39, et polynucleotide codant ce polypeptide | |
| WO2001075036A3 (fr) | Nouveau polypeptide, immunophiline humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001074996A3 (fr) | Nouveau polypeptide, c. elegans 52 humain, et polynucléotide codant pour ce polypeptide | |
| WO2001075035A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075034A3 (fr) | Nouveau polypeptide, peroxydase proteine humaine 15, et polynucleotide codant pour ce polypeptide | |
| WO2001075029A3 (fr) | Nouveau polypeptide, facteur humain 11 associe a nf-e2, et polynucleotide codant pour ce polypeptide | |
| WO2001081536A3 (fr) | Nouveau polypeptide, proteine kinase ysk1 humaine 10, et polynucleotide codant pour ce polypeptide | |
| WO2001075053A3 (fr) | Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide | |
| WO2001075041A3 (fr) | Nouveau polypeptide, proteine humaine associee a l'epilepsie 11, et polynucleotide codant pour ce polypeptide | |
| WO2001075025A3 (fr) | Nouveau polypeptide, thyroglobuline humaine 9, et polynucleotide codant pour ce polypeptide | |
| WO2001075010A3 (fr) | Nouveau polypeptide, proteine humaine de transduction nucleaire 25 contenant un domaine structurel atp/gtp, et polynucleotide codant pour ce polypeptide | |
| WO2001079439A3 (fr) | Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide | |
| WO2001079431A3 (fr) | Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide | |
| WO2001087961A1 (fr) | Nouveau polypeptide, proteine pax humaine 11.4, et polynucleotide codant pour ce polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| 122 | Ep: pct application non-entry in european phase | ||
| NENP | Non-entry into the national phase |
Ref country code: JP |